This book presents a company-based view of the recent progresses in fragment-based drug discovery (FBDD). The book is highly focussed on methodologies. However, theory is only briefly introduced leaving ample space for the discussion of their implementation fn drug discovery campaigns, thereby giving the reader a clear sense of their applicability and usefulness. Most of the examples come from pharmaceutical drug discovery programs led by the authors them- selves, most of which are from the industry side.
展开▼